Description of the medicine: Trioxazine (Trioxazin)
TRIOXAZIN (Trioxazin). 4- (3, 4, 5-trimethoxybenzoyl) -morpholine, or N- (3, 4, 5-trimethoxybenzoyl) -tetrahydro-1, 4-oxazine.
Synonyms: Trimethosine, Sedoxazin, Trimetozinum, Trimetozine.
It has a moderate tranquilizing effect, combined with activation, a slight increase in mood without drowsiness and intellectual inhibition. It does not suppress mono- and polysynaptic reflexes, and therefore does not have a muscle relaxant effect.
Used for neurotic disorders occurring with a predominance of hyposthenic manifestations (adynamia, lethargy, lethargy).
The drug is prescribed orally (after eating), usually 0.3 g (1 tablet) 2 times a day. In mild neurotic conditions, the daily dose may be 0.6 - 0.9 g (1 tablet 2 to 3 times a day), and with severe symptoms, increase the dose after 3 - 4 days to 1, 2 - 1, 8 g per day (4-6 tablets in total; in some cases, the dose may be increased to 10 tablets per day).
Children are prescribed in smaller doses in accordance with the age of 1 / 4-1 / 2 1 tablet up to 3-5 times a day).
Trioxazine is usually well tolerated and can be used on an inpatient and outpatient basis. When taking relatively large doses, weakness, lethargy, mild nausea, drowsiness, in some cases allergic reactions, dyspeptic symptoms, dry mouth and throat can be observed. An increase in anxiety, tension, and fear is rarely noted. With prolonged use of trioxazine (as well as other tranquilizers), development of mental addiction is possible.
Release form: tablets of 0.3 g in a package of 20 pieces.
Storage: List B.